Léčivé přípravky pro kardiovaskulární systém V. - Praluent
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 9456334 | 09/17/2019 | sanofi-aventis, s.r.o. | 10,061,139.00 | 9,146,490.00 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| 332_Písemná zpráva.pdf | Písemná zpráva zadavatele | 10/04/2019, 11:59 AM | Dokument není zavirovaný |
List of Participants
| Show detail | |||||||
|---|---|---|---|---|---|---|---|
| sanofi-aventis, s.r.o. | Praha | 10,061,135.17 | 9,146,486.52 | CZK |
Price Actually Paid in Each Year of Performance
| 9456334 | 2021 | 3,831,946.37 | 3,483,587.61 |
| 9456334 | 2020 | 855,269.00 | 777,518.00 |
| 9456334 | 2019 | 125,775.05 | 114,340.95 |